Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2020

Nov 30, 2020

30071_dirs_2020-11-30_205c1e75-bc8e-457d-a2ae-223499a33ebe.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2020-11-27

Reporting Person: De Witte Jan (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-11-27 ReMed Common Stock F 183 $212.11 Disposed 4137 Direct

Footnotes

F1: Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/21/2019.